Under normal circumstances, PML competitively binds with β-catenin to promote non- canonical, tumor suppressive β-catenin signaling, while reducing with its involvement in canonical, oncogenic Wnt/β-catenin signaling. This evidence concerns the gene PML and neoplasm.